Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

A Pharmacoepidemiologic Study of the Safety and Effectiveness of Clindamycin in Infants.

Greenberg RG, Wu H, Maharaj A, Cohen-Wolkowiez M, Tomashek KM, Osborn BL, Clark RH, Walter EB.

Pediatr Infect Dis J. 2019 Nov 5. doi: 10.1097/INF.0000000000002524. [Epub ahead of print]

PMID:
31725114
2.

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.

Bernstein DI, Guptill J, Naficy A, Nachbagauer R, Berlanda-Scorza F, Feser J, Wilson PC, Solórzano A, Van der Wielen M, Walter EB, Albrecht RA, Buschle KN, Chen YQ, Claeys C, Dickey M, Dugan HL, Ermler ME, Freeman D, Gao M, Gast C, Guthmiller JJ, Hai R, Henry C, Lan LY, McNeal M, Palm AE, Shaw DG, Stamper CT, Sun W, Sutton V, Tepora ME, Wahid R, Wenzel H, Wohlbold TJ, Innis BL, García-Sastre A, Palese P, Krammer F.

Lancet Infect Dis. 2019 Oct 17. pii: S1473-3099(19)30393-7. doi: 10.1016/S1473-3099(19)30393-7. [Epub ahead of print]

3.

Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.

Hills SL, Walter EB, Atmar RL, Fischer M; ACIP Japanese Encephalitis Vaccine Work Group.

MMWR Recomm Rep. 2019 Jul 19;68(2):1-33. doi: 10.15585/mmwr.rr6802a1.

4.

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.

Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB.

MMWR Recomm Rep. 2019 Aug 23;68(3):1-21. doi: 10.15585/mmwr.rr6803a1.

5.

Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.

Munoz FM, Anderson EJ, Bernstein DI, Harrison CJ, Pahud B, Anderson E, Creech CB, Berry AA, Kotloff KL, Walter EB, Atmar RL, Bellamy AR, Chang S, Keitel WA.

Vaccine. 2019 Aug 23;37(36):5161-5170. doi: 10.1016/j.vaccine.2019.07.085. Epub 2019 Jul 30.

PMID:
31375440
6.

Improving Influenza Prevention: Modest Changes with Large Effects.

Walter EB, Atmar RL.

Clin Infect Dis. 2019 Jul 25. pii: ciz683. doi: 10.1093/cid/ciz683. [Epub ahead of print] No abstract available.

PMID:
31344224
7.

Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study.

Edwards JM, Watson N, Focht C, Wynn C, Todd CA, Walter EB, Heine RP, Swamy GK.

Infect Dis Obstet Gynecol. 2019 Feb 3;2019:5430493. doi: 10.1155/2019/5430493. eCollection 2019.

8.

An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.

Woods CW, Sanchez AM, Swamy GK, McClain MT, Harrington L, Freeman D, Poore EA, Slifka DK, Poer DeRaad DE, Amanna IJ, Slifka MK, Cai S, Shahamatdar V, Wierzbicki MR, Amegashie C, Walter EB.

Vaccine. 2019 Jul 9;37(30):4222-4230. doi: 10.1016/j.vaccine.2018.12.026. Epub 2019 Jan 18.

9.

Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.

Fortner KB, Swamy GK, Broder KR, Jimenez-Truque N, Zhu Y, Moro PL, Liang J, Walter EB, Heine RP, Moody MA, Yoder S, Edwards KM.

Vaccine. 2018 Oct 8;36(42):6354-6360. doi: 10.1016/j.vaccine.2018.07.012. Epub 2018 Sep 13.

10.

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.

Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB.

MMWR Recomm Rep. 2018 Aug 24;67(3):1-20. doi: 10.15585/mmwr.rr6703a1.

11.

Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.

Brady RC, Jackson LA, Frey SE, Shane AL, Walter EB, Swamy GK, Schlaudecker EP, Szefer E, Wolff M, McNeal MM, Bernstein DI, Steinhoff MC.

Vaccine. 2018 Jul 25;36(31):4663-4671. doi: 10.1016/j.vaccine.2018.06.036. Epub 2018 Jun 28.

PMID:
29961606
12.

Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) - United States, 2018-19 Influenza Season.

Grohskopf LA, Sokolow LZ, Fry AM, Walter EB, Jernigan DB.

MMWR Morb Mortal Wkly Rep. 2018 Jun 8;67(22):643-645. doi: 10.15585/mmwr.mm6722a5.

13.

Drinking Water to Prevent Postvaccination Presyncope in Adolescents: A Randomized Trial.

Kemper AR, Barnett ED, Walter EB, Hornik C, Pierre-Joseph N, Broder KR, Silverstein M, Harrington T.

Pediatrics. 2017 Nov;140(5). pii: e20170508. doi: 10.1542/peds.2017-0508.

14.

The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.

Walter EB, Hornik CP, Grohskopf L, McGee CE, Todd CA, Museru OI, Harrington L, Broder KR.

Vaccine. 2017 Dec 4;35(48 Pt B):6664-6671. doi: 10.1016/j.vaccine.2017.10.020. Epub 2017 Oct 19.

15.

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.

Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Bresee JS, Fry AM, Jernigan DB.

MMWR Recomm Rep. 2017 Aug 25;66(2):1-20. doi: 10.15585/mmwr.rr6602a1.

16.

The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder.

Belongia EA, Karron RA, Reingold A, Walter EB, Bennett NM.

Vaccine. 2018 Jan 8;36(3):343-344. doi: 10.1016/j.vaccine.2017.06.017. Epub 2017 Jul 3. No abstract available.

PMID:
28684166
17.

Parental Approach to the Prevention and Management of Fever and Pain Following Childhood Immunizations: A Survey Study.

Saleh E, Swamy GK, Moody MA, Walter EB.

Clin Pediatr (Phila). 2017 May;56(5):435-442. doi: 10.1177/0009922816675116. Epub 2016 Oct 23.

18.

Rotavirus Vaccine and Intussusception Hospitalizations.

Walter EB, Staat MA.

Pediatrics. 2016 Sep;138(3). pii: e20161952. doi: 10.1542/peds.2016-1952. Epub 2016 Aug 24. No abstract available.

19.

State-Level Immunization Information Systems: Potential for Childhood Immunization Data Linkages.

Fuller JE, Walter EB Jr, Dole N, O'Hara R, Herring AH, Durkin MS, Specker B, Wey B.

Matern Child Health J. 2017 Jan;21(1):29-35. doi: 10.1007/s10995-016-2090-1.

20.

Effect of antipyretic analgesics on immune responses to vaccination.

Saleh E, Moody MA, Walter EB.

Hum Vaccin Immunother. 2016 Sep;12(9):2391-402. doi: 10.1080/21645515.2016.1183077. Epub 2016 May 31. Review.

21.

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules.

Libster R, McNeal M, Walter EB, Shane AL, Winokur P, Cress G, Berry AA, Kotloff KL, Sarpong K, Turley CB, Harrison CJ, Pahud BA, Marbin J, Dunn J, El-Khorazaty J, Barrett J, Edwards KM; VTEU Rotavirus Vaccine Study Work Group.

Pediatrics. 2016 Feb;137(2):e20152603. doi: 10.1542/peds.2015-2603. Epub 2016 Jan 28.

22.

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.

Mbawuike IN, Atmar RL, Patel SM, Corry DB, Winokur PL, Brady RC, Chen WH, Edwards KM, Creech CB, Walter EB Jr, Frey SE, Belshe RB, Goll JB, Hill H, Keitel WA.

Vaccine. 2016 Jan 20;34(4):547-554. doi: 10.1016/j.vaccine.2015.11.055. Epub 2015 Dec 4.

23.

Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009.

Weiss T, Zhang D, Borse NN, Walter EB.

Vaccine. 2015 Nov 27;33(48):6871-7. doi: 10.1016/j.vaccine.2015.07.065. Epub 2015 Aug 7.

24.

Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina.

Chung RJ, Walter EB, Kemper AR, Dayton A.

J Adolesc Health. 2015 May;56(5 Suppl):S14-6. doi: 10.1016/j.jadohealth.2014.10.272.

PMID:
25863548
25.

Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals.

Russell K, Dunne EF, Kemper AR, Dolor RJ, Unger ER, Panicker G, Markowitz LE, Walter EB.

Vaccine. 2015 Apr 15;33(16):1953-8. doi: 10.1016/j.vaccine.2015.02.058. Epub 2015 Mar 3.

PMID:
25744229
26.

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.

Belshe RB, Frey SE, Graham IL, Anderson EL, Jackson LA, Spearman P, Edupuganti S, Mulligan MJ, Rouphael N, Winokur P, Dolor RJ, Woods CW, Walter EB, Chen WH, Turley C, Edwards KM, Creech CB, Hill H, Bellamy AR; National Institute of Allergy and Infectious Diseases–Funded Vaccine and Treatment Evaluation Units.

JAMA. 2014 Oct 8;312(14):1420-8. doi: 10.1001/jama.2014.12609.

PMID:
25291578
27.

Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.

Kotloff KL, Halasa NB, Harrison CJ, Englund JA, Walter EB, King JC, Creech CB, Healy SA, Dolor RJ, Stephens I, Edwards KM, Noah DL, Hill H, Wolff M.

Pediatr Infect Dis J. 2014 Aug;33(8):865-71. doi: 10.1097/INF.0000000000000329.

28.

Pain in adolescent girls receiving human papillomavirus vaccine with concomitantly administered vaccines.

Walter EB, Kemper AR, Dolor RJ, Dunne EF.

Pediatr Infect Dis J. 2015 Feb;34(2):200-2. doi: 10.1097/INF.0000000000000537.

PMID:
25170553
29.

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.

Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, Karron RA, Walter EB; Centers for Disease Control and Prevention.

MMWR Morb Mortal Wkly Rep. 2014 Aug 15;63(32):691-7.

30.

Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.

Jackson KJ, Liu Y, Roskin KM, Glanville J, Hoh RA, Seo K, Marshall EL, Gurley TC, Moody MA, Haynes BF, Walter EB, Liao HX, Albrecht RA, García-Sastre A, Chaparro-Riggers J, Rajpal A, Pons J, Simen BB, Hanczaruk B, Dekker CL, Laserson J, Koller D, Davis MM, Fire AZ, Boyd SD.

Cell Host Microbe. 2014 Jul 9;16(1):105-14. doi: 10.1016/j.chom.2014.05.013. Epub 2014 Jun 26.

31.

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.

Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ.

JAMA. 2014 May 7;311(17):1760-9. doi: 10.1001/jama.2014.3633. Erratum in: JAMA. 2017 Jan 24;317(4):442. JAMA. 2017 Jan 24;317(4):441-442.

32.

Engaging expectant parents to receive Tdap vaccination.

Steiner B, Swamy GK, Walter EB.

Am J Perinatol. 2014 May;31(5):407-12. doi: 10.1055/s-0033-1352483. Epub 2013 Aug 5.

PMID:
23918521
33.

Pneumococcal conjugate vaccine: are 3 doses equal to 4 doses?

Walter EB, Clements DA.

Pediatrics. 2013 Aug;132(2):e498-9. doi: 10.1542/peds.2013-1573. Epub 2013 Jul 1. No abstract available.

PMID:
23821696
34.

2009 H1N1 and seasonal influenza immunization among pregnant women: a comparison of different sources of immunization information.

Specker B, Wey B, Fuller J, Sandoval MN, Durkin M, Dole N, Walter EB Jr.

Matern Child Health J. 2014 Apr;18(3):681-7. doi: 10.1007/s10995-013-1293-y.

35.

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.

Frey SE, Winokur PL, Salata RA, El-Kamary SS, Turley CB, Walter EB Jr, Hay CM, Newman FK, Hill HR, Zhang Y, Chaplin P, Tary-Lehmann M, Belshe RB.

Vaccine. 2013 Jun 24;31(29):3025-33. doi: 10.1016/j.vaccine.2013.04.050. Epub 2013 May 9.

36.

Immunizations for preteens.

Walter EB, Chung RJ.

N C Med J. 2013 Jan-Feb;74(1):66-71.

PMID:
23530388
37.

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

Chen WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, Wolff M, Kotloff KL; Pandemic H1N1 Vaccine Adult Study Group.

Vaccine. 2012 Jun 13;30(28):4240-8. doi: 10.1016/j.vaccine.2012.04.044. Epub 2012 Apr 23.

38.

H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination.

Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, McClain MT, Denny TN, Chen X, Munshaw S, Marshall DJ, Whitesides JF, Drinker MS, Amos JD, Gurley TC, Eudailey JA, Foulger A, DeRosa KR, Parks R, Meyerhoff RR, Yu JS, Kozink DM, Barefoot BE, Ramsburg EA, Khurana S, Golding H, Vandergrift NA, Alam SM, Tomaras GD, Kepler TB, Kelsoe G, Liao HX, Haynes BF.

PLoS One. 2011;6(10):e25797. doi: 10.1371/journal.pone.0025797. Epub 2011 Oct 19.

39.

The effectiveness of a primary care-based pediatric obesity program.

Dolinsky DH, Armstrong SC, Walter EB, Kemper AR.

Clin Pediatr (Phila). 2012 Apr;51(4):345-53. doi: 10.1177/0009922811425232. Epub 2011 Oct 19.

PMID:
22013148
40.

Healthy-days time equivalents for outcomes of acute rotavirus infections.

Hauber AB, Itzler R, Johnson FR, Mohamed AF, González JM, Cook JR, Walter EB.

Vaccine. 2011 Oct 19;29(45):8086-93. doi: 10.1016/j.vaccine.2011.08.041. Epub 2011 Aug 22.

PMID:
21864612
41.

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin.

Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, Golding H, Dormitzer PR, Haynes BF, Walter EB, Moody MA, Kepler TB, Liao HX, Harrison SC.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21. doi: 10.1073/pnas.1111497108. Epub 2011 Aug 8.

42.
43.

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.

Frenck RW Jr, Belshe R, Brady RC, Winokur PL, Campbell JD, Treanor J, Hay CM, Dekker CL, Walter EB Jr, Cate TR, Edwards KM, Hill H, Wolff M, Leduc T, Tornieporth N.

Vaccine. 2011 Aug 5;29(34):5666-74. doi: 10.1016/j.vaccine.2011.06.010. Epub 2011 Jun 23.

44.

The HPV vaccine: are dosing recommendations being followed?

Tan W, Viera AJ, Rowe-West B, Grimshaw A, Quinn B, Walter EB.

Vaccine. 2011 Mar 21;29(14):2548-54. doi: 10.1016/j.vaccine.2011.01.066. Epub 2011 Feb 5.

PMID:
21300098
45.

Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates.

Walter EB, Allred NJ, Swamy GK, Hellkamp AS, Dolor RJ.

Infect Control Hosp Epidemiol. 2010 Oct;31(10):1070-3. doi: 10.1086/656563.

PMID:
20804416
46.

Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally?

Walter EB, Rajagopal S, Zhu Y, Neuzil KM, Fairchok MP, Englund JA.

Vaccine. 2010 Jun 17;28(27):4376-83. doi: 10.1016/j.vaccine.2010.04.058. Epub 2010 May 4.

PMID:
20447477
47.

Burden of childhood rotavirus disease on health systems in the United States.

Mast TC, Walter EB, Bulotsky M, Khawaja SS, DiStefano DJ, Sandquist MK, Straus WL, Staat MA.

Pediatr Infect Dis J. 2010 Feb;29(2):e19-25.

PMID:
20135751
48.

Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study.

Walter EB, Englund JA, Blatter M, Nyberg J, Ruben FL, Decker MD; GRC27 Study Team.

Pediatr Infect Dis J. 2009 Dec;28(12):1099-104. doi: 10.1097/INF.0b013e3181b0c0ca.

PMID:
19935270
49.

Cocooning infants: Tdap immunization for new parents in the pediatric office.

Walter EB, Allred N, Rowe-West B, Chmielewski K, Kretsinger K, Dolor RJ.

Acad Pediatr. 2009 Sep-Oct;9(5):344-7. doi: 10.1016/j.acap.2009.05.027. Epub 2009 Jul 12.

PMID:
19596219
50.

The impact of rotavirus gastroenteritis on the family.

Mast TC, DeMuro-Mercon C, Kelly CM, Floyd LE, Walter EB.

BMC Pediatr. 2009 Feb 6;9:11. doi: 10.1186/1471-2431-9-11.

Supplemental Content

Loading ...
Support Center